U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults

FDA considering ban on popular artificial red dye found in candy, drinks

The MODD-1 insulin pump just got FDA clearance. Full interview on the Diabetech Youtube channel. #diabetes #t1d #t2d | Diabetech Justin

‘Disastrous’: Rita Panahi’s top 5 worst moments of Kamala Harris’ Fox News interview

'I feel very confident about the decision we made' on vaccine: FDA commissioner

Many consumer groups feel that the U.S. Food and Drug Administration (FDA) drug approval process is too easy and, as a result, too many drugs are approved that are later found to be unsafe. On the other hand, a number of industry lobbyists have pushed for a more lenient approval process so that pharmaceutical companies can get new drugs approved more easily and quickly. Consider a null hypothesis that a new, unapproved drug is unsafe and an alternative hypothesis that a new, unapproved drug is s